The role of chemokines in human cardiovascular pathology: Enhanced biological insights

Atherosclerosis

Volumn 160, Issue 1, 2002, Pages 91-102

  Shin, William S ^a   Szuba, Andrzej ^a   Rockson, Stanley G ^b  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Atherogenesis; Atherosclerosis; Chemokines

Indexed keywords

CHEMOKINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 8; MONOCYTE CHEMOTACTIC PROTEIN 1; TISSUE INHIBITOR OF METALLOPROTEINASE 1;

ATHEROGENESIS; ATHEROSCLEROSIS; BLOOD VESSEL WALL; CYTOKINE RELEASE; ENDOTHELIUM CELL; HUMAN; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW;

EID: 0036149025     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9150(01)00571-8     Document Type: Article

References (103)

1. Plaque disruption and thrombosis. Potential role of inflammation and infection
2. Circulating markers of inflammation for vascular risk prediction: Are they ready for prime time
3. Atherosclerosis - An inflammatory disease
4. Inflammation, pravastatin, and the risk of coronary events after myocardial infarction in patients with average cholesterol levels
5. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men
6. The biology of atherosclerosis
7. MCP-1 deficiency reduces susceptibility to atherosclerosis in mice that overexpress human apolipoprotein B
8. A leukocyte homologue of the IL-8 receptor CXCR-2 mediates the accumulation of macrophages in atherosclerotic lesions of LDL receptor-deficient mice
9. Heterozygous osteopetrotic (op) mutation reduces atherosclerosis in LDL receptor- deficient mice
10. Monocyte chemoattractant protein-1 enhances expression of intercellular adhesion molecule-1 following ischemia-reperfusion of the liver in rats
11. Chemokines in allergic inflammation
12. Chemokines-chemotactic cytokines that mediate inflammation
13. The role of CXC chemokines in the regulation of angiogenesis in non-small cell lung cancer
14. The CXC chemokine, monokine induced by interferon-γ, inhibits non-small cell lung carcinoma tumor growth and metastasis
15. Interferon-inducible protein-10 involves vascular smooth muscle cell migration, proliferation, and inflammatory response
16. Interleukin-8. A mitogen and chemoattractant for vascular smooth muscle cells
17. Tissue factor is induced by monocyte chemoattractant protein-1 in human aortic smooth muscle and THP-1 cells
18. Chemokines
19. Purification and partial biochemical characterization of a human monocyte-derived, neutrophil-activating peptide that lacks interleukin 1 activity
20. Purification and amino acid sequencing of NAF, a novel neutrophil-activating factor produced by monocytes
21. Purification of a human monocyte-derived neutrophil chemotactic factor that has peptide sequence similarity to other host defense cytokines
22. Purification and characterization of a novel monocyte chemotactic and activating factor produced by a human myelomonocytic cell line
23. Purification and amino acid analysis of two human glioma-derived monocyte chemoattractants
24. Macrophages secrete a novel heparin-binding protein with inflammatory and neutrophil chemokinetic properties
25. Chemokine receptors: Gateways to inflammation and infection
26. The molecular biology of leukocyte chemoattractant receptors
27. High-resolution solution structure of the beta chemokine hMIP-1β by multidimensional NMR
28. Role of Rho in chemoattractant-activated leukocyte adhesion through integrins
29. Leukocyte-endothelial cell recognition: Three (or more) steps to specificity and diversity
30. Traffic signals for lymphocyte recirculation and leukocyte emigration: The multistep paradigm
31. Selective expression of the eotaxin receptor CCR3 by human T helper 2 cells
32. Interleukin-2 regulates CC chemokine receptor expression and chemotactic responsiveness in T lymphocytes
33. Bacterial lipopolysaccharide rapidly inhibits expression of C-C chemokine receptors in human monocytes
34. High levels of interleukin-8 in the blood and alveolar spaces of patients with pneumonia and adult respiratory distress syndrome
35. Upregulation of RANTES in psoriatic keratinocytes: A possible pathogenic mechanism for psoriasis
36. Detection of a gamma interferon-induced protein IP-10 in psoriatic plaques
37. Monocyte chemoattractant protein-1 in human atheromatous plaques
38. Increased expression of the monocyte chemoattractant protein-1 in bronchial tissue from asthmatic subjects
39. Bronchial mucosal expression of the genes encoding chemokines RANTES and MCP-3 in symptomatic atopic and nonatopic asthmatics: Relationship to the eosinophil-active cytokines interleukin (IL)-5, granulocyte macrophage-colony-stimulating factor, and IL-3
40. Increased expression of eotaxin in bronchoalveolar lavage and airways of asthmatics contributes to the chemotaxis of eosinophils to the site of inflammation
41. Human eotaxin is a specific chemoattractant for eosinophil cells and provides a new mechanism to explain tissue eosinophilia
42. Monocyte-chemoattractant protein 1 gene expression in intestinal epithelial cells and inflammatory bowel disease mucosa
43. 'The good, the bad, and the ugly': The role of chemokines in models of human disease
44. Prevention of lung reperfusion injury in rabbits by a monoclonal antibody against interleukin-8
45. Requirement of MIP-1 α for an inflammatory response to viral infection
46. Eosinophil recruitment to the lung in a murine model of allergic inflammation. The role of T cells, chemokines, and adhesion receptors
47. Monocyte chemotactic protein-3 (MCP-3)/fibroblast-induced cytokine (FIC) in eosinophilic inflammation of the airways and the inhibitory effects of an anti-MCP-3/FIC antibody
48. Differential recruitment of leukocyte populations and alteration of airway hyperreactivity by C-C family chemokines in allergic airway inflammation
49. Targeted disruption of the chemokine eotaxin partially reduces antigen-induced tissue eosinophilia
50. Prevention of proteinuria by the administration of anti-interleukin 8 antibody in experimental acute immune complex-induced glomerulonephritis
51. Human endothelium as a source of multifunctional cytokines: Molecular regulation and possible role in human disease
52. Interleukin 8 is induced by cholesterol loading of macrophages and expressed by macrophage foam cells in human atheroma
53. Linkage between inflammation and coagulation: An update on the molecular basis of the crosstalk
54. New insight into coronary endothelial dysfunction: Role of endothelin
55. Multifunctional cytokine expression by human coronary endothelium and regulation by monokines and glucocorticoids
56. IL-1 transcriptionally activates the neutrophil chemotactic factor/IL-8 gene in endothelial cells
57. The receptor for interleukin 3 is selectively induced in human endothelial cells by tumor necrosis factor alpha and potentiates interleukin 8 secretion and neutrophil transmigration
58. Interleukin-4 and interleukin-10 increase endotoxin-stimulated human umbilical vein endothelial cell interleukin-8 release
59. Phospholipase C and perfringolysin O from Clostridium perfringens upregulate endothelial cell-leukocyte adherence molecule 1 and intercellular leukocyte adherence molecule 1 expression and induce interleukin-8 synthesis in cultured human umbilical vein endothelial cells
60. TNF-α-induced transendothelial neutrophil migration is IL-8 dependent
61. Interleukin-8 is a potent mediator of eosinophil chemotaxis through endothelium and epithelium
62. Nitric oxide decreases cytokine-induced endothelial activation. Nitric oxide selectively reduces endothelial expression of adhesion molecules and proinflammatory cytokines
63. Monocyte chemotactic and activating factor gene expression induced in endothelial cells by IL-1 and tumor necrosis factor
64. MCP-1 and IL-8 trigger firm adhesion of monocytes to vascular endothelium under flow conditions
65. Differential immobilization and hierarchical involvement of chemokines in monocyte arrest and transmigration on inflamed endothelium in shear flow
66. Differential chemokine receptor expression and function in human monocyte subpopulations
67. Chemokines: Leucocyte recruitment and activation cytokines
68. Monocyte chemoattractant protein-1 accelerates atherosclerosis in apolipoprotein E-deficient mice
69. Interleukin-8 mediates downregulation of tissue inhibitor of metalloproteinase-1 expression in cholesterol-loaded human macrophages: Relevance to stability of atherosclerotic plaque
70. Interleukin-8 gene induction in the myocardium after ischemia and reperfusion in vivo
71. Signal transduction in atherosclerosis: Integration of cytokines and the eicosanoid network
72. Minimally modified low density lipoprotein stimulates monocyte endothelial interactions
73. Cytokine-activated human endothelial cells synthesize and secrete a monocyte chemoattractant, MCP-1/JE
74. Lysophosphatidylcholine stimulates the expression and production of MCP-1 by human vascular endothelial cells
75. Nitric oxide modulates the expression of monocyte chemoattractant protein 1 in cultured human endothelial cells
76. The pathogenesis of atherosclerosis (second of two parts)
77. American Association of Pathologists president's address. New roles for the endothelium in inflammation and immunity
78. Modified low density lipoproteins suppress production of a platelet-derived growth factor-like protein by cultured endothelial cells
79. Lipoprotein-mediated inhibition of endothelial cell production of platelet-derived growth factor-like protein depends on free radical lipid peroxidation
80. Vascular wall growth control: The role of the endothelium
81. Nitric oxide inhibits macrophage-colony stimulating factor gene transcription in vascular endothelial cells
82. The value of apolipoprotein E knockout mice for studying the effects of dietary fat and cholesterol on atherogenesis
83. Absence of monocyte chemoattractant protein-1 reduces atherosclerosis in low density lipoprotein receptor-deficient mice
84. Absence of CC chemokine receptor-2 reduces atherosclerosis in apolipoprotein E-deficient mice
85. Chemokine receptor CCR2 expression and monocyte chemoattractant protein-1-mediated chemotaxis in human monocytes. A regulatory role for plasma LDL
86. Atherogenic properties of enzymatically degraded LDL: Selective induction of MCP-1 and cytotoxic effects on human macrophages
87. Estradiol suppresses MCP-1 expression in vivo: Implications for atherosclerosis
88. Dysregulation of monocytic nuclear factor-κB by oxidized low-density lipoprotein
89. Activated platelets induce monocyte chemotactic protein-1 secretion and surface expression of intercellular adhesion molecule-1 on endothelial cells
90. Angiotensin-converting enzyme inhibition prevents arterial nuclear factor-κB activation, monocyte chemoattractant protein-1 expression, and macrophage infiltration in a rabbit model of early accelerated atherosclerosis
91. ACE inhibitor quinapril reduces the arterial expression of NF-κB-dependent proinflammatory factors but not of collagen I in a rabbit model of atherosclerosis
92. HMG-CoA reductase inhibition by atorvastatin reduces neointimal inflammation in a rabbit model of atherosclerosis
93. Macrophages isolated from human atherosclerotic plaques produce IL-8, and oxysterols may have a regulatory function for IL-8 production
94. High glucose enhances the gene expression of interleukin-8 in human endothelial cells, but not in smooth muscle cells: Possible role of interleukin-8 in diabetic macroangiopathy
95. Expression and cellular localization of the CC chemokines PARC and ELC in human atherosclerotic plaques
96. Neutrophil chemoattractants generated in two phases during reperfusion of ischemic myocardium in the rabbit. Evidence for a role for C5a and interleukin-8
97. Inhibition of interleukin-8 blocks myocardial ischemia-reperfusion injury
98. Prevention of cerebral edema and infarct in cerebral reperfusion injury by an antibody to interleukin-8
99. Anti-rat IL-8 (CINC) monoclonal antibody administration reduces ischemia-reperfusion injury in small intestine
100. A novel strategy for myocardial protection using in vivo transfection of cis element 'decoy' against NF-κB binding site: Evidence for a role of NF-κB in ischemia-reperfusion injury
101. Induction of monocyte chemoattractant protein-1 in the small veins of the ischemic and reperfused canine myocardium
102. Release of chemoattractants for human monocytes from endothelial cells by interaction with neutrophils
103. Prevention of myocardial reperfusion injury in rats by an antibody against monocyte chemotactic and activating factor/monocyte chemoattractant protein-1